Exosens (XPAR:EXENS) Cash And Cash Equivalents : €123.2 Mil (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Exosens Cash And Cash Equivalents?

Exosens's quarterly cash and cash equivalents declined from Dec. 2023 (€15.46 Mil) to Mar. 2024 (€14.09 Mil) but then increased from Mar. 2024 (€14.09 Mil) to Jun. 2024 (€123.17 Mil).

Exosens's annual cash and cash equivalents increased from Dec. 2021 (€15.93 Mil) to Dec. 2022 (€28.96 Mil) but then declined from Dec. 2022 (€28.96 Mil) to Dec. 2023 (€15.46 Mil).

Exosens Cash And Cash Equivalents Historical Data

The historical data trend for Exosens's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exosens Cash And Cash Equivalents Chart

Exosens Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

31.14

15.93

28.96

15.46

Exosens Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Cash And Cash Equivalents	Get a 7-Day Free Trial			-	-	15.46	14.09	123.17

Exosens Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Exosens (XPAR:EXENS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Exosens Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Exosens's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Exosens Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Exosens SA (XPAR:EXENS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

0EXO:UK EXENSp:UK H8Y:Germany

Address

18 Avenue Pythagore, Domaine de Pelus - Axis Business Park - Bât 5 E, Merignac, FRA, 33700

Website

https://www.exosens.com

Exosens SA is a high-tech company in innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. It offers its customers detection components and solutions such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes. Its products include Night vision tubes, Ultra Violet cameras, Ion and electron detection, Gamma detectors, etc.

Exosens Headlines

No Headlines